US Stock MarketDetailed Quotes

GTBP GT Biopharma

Watchlist

2.8000
-0.0600-2.10%

Close Nov 29 13:00 ET

2.8000
0.00000.00%

Post 17:01 ET

6.26MMarket Cap-375P/E (TTM)

GT Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-59.92%6.42M

-48.54%9.25M

-50.72%9.81M

-15.36%13.97M

-22.95%16.01M

-24.24%17.97M

-25.58%19.9M

-48.38%16.51M

-Cash and cash equivalents

142.37%6.42M

234.26%9.25M

-4.65%1.95M

-80.98%1.08M

7.42%2.65M

-48.36%2.77M

-71.93%2.05M

-36.75%5.67M

-Short-term investments

--0

-55.99%7.86M

18.98%12.89M

-27.04%13.37M

-17.21%15.21M

-8.22%17.85M

-52.91%10.84M

Restricted cash

--93K

----

Other current assets

552.63%248K

-62.50%18K

105.26%78K

55.56%84K

-56.82%38K

-78.38%48K

-91.61%38K

-71.58%54K

Total current assets

-57.89%6.76M

-48.58%9.27M

-50.42%9.89M

-15.13%14.06M

-23.09%16.05M

-24.75%18.02M

-26.68%19.94M

-48.52%16.56M

Non current assets

Net PPE

--0

-80.71%27K

-67.88%53K

-54.21%87K

-46.73%114K

-40.93%140K

--165K

-Gross PPE

--0

-80.71%27K

-67.88%53K

-54.21%87K

-46.73%114K

-40.93%140K

--165K

Non current prepaid assets

----

--0

0.00%9K

--9K

Total non current assets

--0

-81.88%27K

-69.54%53K

-51.76%96K

-44.84%123K

-39.43%149K

--174K

Total assets

-58.14%6.76M

-48.93%9.27M

-50.65%9.91M

-15.70%14.11M

-23.36%16.15M

-24.93%18.14M

-26.80%20.09M

-47.97%16.74M

Liabilities

Current liabilities

Payables

-34.21%2.61M

-50.96%1.72M

2.62%3.21M

37.83%4.33M

19.40%3.97M

-51.80%3.5M

-61.41%3.13M

-61.66%3.14M

-accounts payable

-34.21%2.61M

-50.96%1.72M

2.62%3.21M

37.83%4.33M

19.40%3.97M

-51.80%3.5M

-61.41%3.13M

-61.66%3.14M

Current accrued expenses

81.71%1.87M

44.44%1.77M

16.16%963K

-28.40%1.2M

-33.12%1.03M

8.24%1.22M

-29.15%829K

-12.20%1.67M

Current debt and capital lease obligation

----

-74.14%30K

-47.27%58K

-13.21%92K

16.50%120K

16.00%116K

254.84%110K

-Current capital lease obligation

--0

-74.14%30K

-47.27%58K

-13.21%92K

16.50%120K

16.00%116K

--110K

Other current liabilities

--182K

--277K

--394K

5,436.84%1.05M

----

-86.23%19K

Current liabilities

-8.41%4.66M

-22.38%3.76M

12.86%4.6M

34.33%6.63M

1.29%5.09M

-43.75%4.84M

-57.11%4.08M

-51.87%4.94M

Non current liabilities

Long term debt and capital lease obligation

----

--0

-78.91%31K

--64K

-Long term capital lease obligation

----

--0

-78.91%31K

--64K

Derivative product liabilities

----

--1.05M

--1.54M

--2.93M

----

Total non current liabilities

--0

1,044.57%1.05M

1,181.67%1.54M

1,911.56%2.96M

--64K

Total liabilities

-24.11%4.66M

-41.09%3.76M

-34.59%4.6M

32.61%6.63M

20.05%6.14M

-26.91%6.38M

-27.12%7.03M

-51.24%5M

Shareholders'equity

Share capital

-93.02%3K

-92.86%3K

-94.74%2K

-94.12%2K

26.47%43K

31.25%42K

15.15%38K

-97.03%34K

-common stock

-95.24%2K

-95.12%2K

-97.30%1K

-96.97%1K

27.27%42K

32.26%41K

15.63%37K

-97.12%33K

-Preferred stock

0.00%1K

Retained earnings

-1.82%-691.45M

-1.68%-688.04M

-1.43%-684.33M

-1.13%-682.07M

-1.53%-679.1M

-2.22%-676.69M

-2.38%-674.7M

-3.20%-674.47M

Paid-in capital

0.65%693.55M

0.75%693.55M

0.28%689.64M

0.49%689.54M

0.62%689.07M

1.62%688.41M

1.62%687.71M

1.75%686.17M

Total stockholders'equity

-79.04%2.1M

-53.18%5.51M

-59.30%5.31M

-36.29%7.48M

-37.29%10.01M

-23.81%11.76M

-26.62%13.05M

-46.44%11.73M

Total equity

-79.04%2.1M

-53.18%5.51M

-59.30%5.31M

-36.29%7.48M

-37.29%10.01M

-23.81%11.76M

-26.62%13.05M

-46.44%11.73M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-59.92%6.42M	-48.54%9.25M	-50.72%9.81M	-15.36%13.97M	-15.36%13.97M	-22.95%16.01M	-24.24%17.97M	-25.58%19.9M	-48.38%16.51M	-48.38%16.51M
-Cash and cash equivalents	142.37%6.42M	234.26%9.25M	-4.65%1.95M	-80.98%1.08M	-80.98%1.08M	7.42%2.65M	-48.36%2.77M	-71.93%2.05M	-36.75%5.67M	-36.75%5.67M
-Short-term investments	--0	--0	-55.99%7.86M	18.98%12.89M	18.98%12.89M	-27.04%13.37M	-17.21%15.21M	-8.22%17.85M	-52.91%10.84M	-52.91%10.84M
Restricted cash	--93K	----	----	----	----	----	----	----	----	----
Other current assets	552.63%248K	-62.50%18K	105.26%78K	55.56%84K	55.56%84K	-56.82%38K	-78.38%48K	-91.61%38K	-71.58%54K	-71.58%54K
Total current assets	-57.89%6.76M	-48.58%9.27M	-50.42%9.89M	-15.13%14.06M	-15.13%14.06M	-23.09%16.05M	-24.75%18.02M	-26.68%19.94M	-48.52%16.56M	-48.52%16.56M
Non current assets
Net PPE	--0	--0	-80.71%27K	-67.88%53K	-67.88%53K	-54.21%87K	-46.73%114K	-40.93%140K	--165K	--165K
-Gross PPE	--0	--0	-80.71%27K	-67.88%53K	-67.88%53K	-54.21%87K	-46.73%114K	-40.93%140K	--165K	--165K
Non current prepaid assets	----	----	----	--0	--0	0.00%9K	0.00%9K	0.00%9K	--9K	--9K
Total non current assets	--0	--0	-81.88%27K	-69.54%53K	-69.54%53K	-51.76%96K	-44.84%123K	-39.43%149K	--174K	--174K
Total assets	-58.14%6.76M	-48.93%9.27M	-50.65%9.91M	-15.70%14.11M	-15.70%14.11M	-23.36%16.15M	-24.93%18.14M	-26.80%20.09M	-47.97%16.74M	-47.97%16.74M
Liabilities
Current liabilities
Payables	-34.21%2.61M	-50.96%1.72M	2.62%3.21M	37.83%4.33M	37.83%4.33M	19.40%3.97M	-51.80%3.5M	-61.41%3.13M	-61.66%3.14M	-61.66%3.14M
-accounts payable	-34.21%2.61M	-50.96%1.72M	2.62%3.21M	37.83%4.33M	37.83%4.33M	19.40%3.97M	-51.80%3.5M	-61.41%3.13M	-61.66%3.14M	-61.66%3.14M
Current accrued expenses	81.71%1.87M	44.44%1.77M	16.16%963K	-28.40%1.2M	-28.40%1.2M	-33.12%1.03M	8.24%1.22M	-29.15%829K	-12.20%1.67M	-12.20%1.67M
Current debt and capital lease obligation	----	----	-74.14%30K	-47.27%58K	-47.27%58K	-13.21%92K	16.50%120K	16.00%116K	254.84%110K	254.84%110K
-Current capital lease obligation	--0	--0	-74.14%30K	-47.27%58K	-47.27%58K	-13.21%92K	16.50%120K	16.00%116K	--110K	--110K
Other current liabilities	--182K	--277K	--394K	5,436.84%1.05M	5,436.84%1.05M	----	----	----	-86.23%19K	-86.23%19K
Current liabilities	-8.41%4.66M	-22.38%3.76M	12.86%4.6M	34.33%6.63M	34.33%6.63M	1.29%5.09M	-43.75%4.84M	-57.11%4.08M	-51.87%4.94M	-51.87%4.94M
Non current liabilities
Long term debt and capital lease obligation	----	----	----	--0	--0	--0	--0	-78.91%31K	--64K	--64K
-Long term capital lease obligation	----	----	----	--0	--0	--0	--0	-78.91%31K	--64K	--64K
Derivative product liabilities	----	----	----	----	----	--1.05M	--1.54M	--2.93M	----	----
Total non current liabilities	--0	--0	--0	--0	--0	1,044.57%1.05M	1,181.67%1.54M	1,911.56%2.96M	--64K	--64K
Total liabilities	-24.11%4.66M	-41.09%3.76M	-34.59%4.6M	32.61%6.63M	32.61%6.63M	20.05%6.14M	-26.91%6.38M	-27.12%7.03M	-51.24%5M	-51.24%5M
Shareholders'equity
Share capital	-93.02%3K	-92.86%3K	-94.74%2K	-94.12%2K	-94.12%2K	26.47%43K	31.25%42K	15.15%38K	-97.03%34K	-97.03%34K
-common stock	-95.24%2K	-95.12%2K	-97.30%1K	-96.97%1K	-96.97%1K	27.27%42K	32.26%41K	15.63%37K	-97.12%33K	-97.12%33K
-Preferred stock	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K
Retained earnings	-1.82%-691.45M	-1.68%-688.04M	-1.43%-684.33M	-1.13%-682.07M	-1.13%-682.07M	-1.53%-679.1M	-2.22%-676.69M	-2.38%-674.7M	-3.20%-674.47M	-3.20%-674.47M
Paid-in capital	0.65%693.55M	0.75%693.55M	0.28%689.64M	0.49%689.54M	0.49%689.54M	0.62%689.07M	1.62%688.41M	1.62%687.71M	1.75%686.17M	1.75%686.17M
Total stockholders'equity	-79.04%2.1M	-53.18%5.51M	-59.30%5.31M	-36.29%7.48M	-36.29%7.48M	-37.29%10.01M	-23.81%11.76M	-26.62%13.05M	-46.44%11.73M	-46.44%11.73M
Total equity	-79.04%2.1M	-53.18%5.51M	-59.30%5.31M	-36.29%7.48M	-36.29%7.48M	-37.29%10.01M	-23.81%11.76M	-26.62%13.05M	-46.44%11.73M	-46.44%11.73M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data